Brown Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-498,348
| Closed | -$7.81M | – | 123 |
|
2019
Q1 | $7.81M | Hold |
498,348
| – | – | 0.08% | 47 |
|
2018
Q4 | $7.69M | Sell |
498,348
-1,985
| -0.4% | -$30.6K | 0.09% | 48 |
|
2018
Q3 | $10.8M | Buy |
500,333
+4,912
| +1% | +$106K | 0.1% | 45 |
|
2018
Q2 | $12M | Buy |
495,421
+151,895
| +44% | +$3.69M | 0.12% | 43 |
|
2018
Q1 | $5.87M | Buy |
343,526
+92,571
| +37% | +$1.58M | 0.07% | 51 |
|
2017
Q4 | $4.76M | Sell |
250,955
-1,349
| -0.5% | -$25.6K | 0.06% | 55 |
|
2017
Q3 | $4.44M | Hold |
252,304
| – | – | 0.05% | 52 |
|
2017
Q2 | $8.38M | Sell |
252,304
-31,626
| -11% | -$1.05M | 0.1% | 50 |
|
2017
Q1 | $9.11M | Sell |
283,930
-5,435
| -2% | -$174K | 0.12% | 48 |
|
2016
Q4 | $10.5M | Sell |
289,365
-4,580
| -2% | -$166K | 0.15% | 46 |
|
2016
Q3 | $13.5M | Buy |
293,945
+42,608
| +17% | +$1.96M | 0.2% | 45 |
|
2016
Q2 | $12.6M | Buy |
251,337
+1,548
| +0.6% | +$77.8K | 0.2% | 46 |
|
2016
Q1 | $13.4M | Buy |
249,789
+1,928
| +0.8% | +$103K | 0.22% | 48 |
|
2015
Q4 | $16.3M | Buy |
247,861
+3,065
| +1% | +$201K | 0.25% | 46 |
|
2015
Q3 | $13.8M | Buy |
244,796
+17,880
| +8% | +$1.01M | 0.24% | 51 |
|
2015
Q2 | $13.4M | Buy |
226,916
+2,911
| +1% | +$172K | 0.22% | 55 |
|
2015
Q1 | $14M | Hold |
224,005
| – | – | 0.23% | 52 |
|
2014
Q4 | $12.9M | Sell |
224,005
-48,073
| -18% | -$2.76M | 0.22% | 53 |
|
2014
Q3 | $14.6M | Buy |
272,078
+2,610
| +1% | +$140K | 0.26% | 54 |
|
2014
Q2 | $14.1M | Sell |
269,468
-6,514
| -2% | -$341K | 0.24% | 56 |
|
2014
Q1 | $14.6M | Sell |
275,982
-2,084
| -0.7% | -$110K | 0.24% | 55 |
|
2013
Q4 | $11.1M | Sell |
278,066
-21,518
| -7% | -$862K | 0.18% | 57 |
|
2013
Q3 | $11.3M | Sell |
299,584
-8,001
| -3% | -$302K | 0.2% | 60 |
|
2013
Q2 | $12.1M | Buy |
+307,585
| New | +$12.1M | 0.26% | 56 |
|